• Home
  • About
    • Team
    • Company
  • Technology
  • Services
    • Discovery Proteomics
    • Efficacy Models
  • Press
  • Portal
  • Contact Us
  • General Info
    • Terms
    • Privacy
  • Home
  • About
    • Team
    • Company
  • Technology
  • Services
    • Discovery Proteomics
    • Efficacy Models
  • Press
  • Portal
  • Contact Us
  • General Info
    • Terms
    • Privacy
Literature

Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers

30 September 2020 0Comments

Highlights Mass-spectrometry-based proteomic profiling of human cancers has the potential for pan-cancer analyses to identify molecular subtypes and associated pathway features that might be otherwise missed using transcriptomics Here, we classify 532 cancers, representing six tissue-based types (breast, colon,…

Read more

Literature

Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups

30 September 2020 0Comments

Highlights • Deep proteomic profiling reveals mechanistic differences among medulloblastomas • Proteomic-defined SHH subtypes do not differ in RNA expression • MYC phosphorylation events define a higher risk subset of group 3 patients • Inhibiting PRKDC may sensitize MYC-activated…

Read more

Literature

Breast cancer quantitative proteome and proteogenomic landscape

30 September 2020 0Comments

Highlights In the preceding decades, molecular characterization has revolutionized breast cancer (BC) research and therapeutic approaches. Presented herein, an unbiased analysis of breast tumor proteomes, inclusive of 9995 proteins quantified across all tumors, for the first time recapitulates BC…

Read more

Literature

Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities

30 September 2020 0Comments

Highlights Systematic identification of colon cancer-associated proteins and phosphosites Proteomics-supported neoantigens and cancer/testis antigens in 78% of the tumors Rb phosphorylation is an oncogenic driver and a putative target in colon cancer Glycolysis inhibition may render MSI tumors more…

Read more

Categories
  • Literature
Search
Tags
global proteomes Mass-spectrometry-based proteomic phospho-proteomes proteogenomic proteome Proteomics transcriptomics
  • Home
  • About
    • Team
    • Company
  • Technology
  • Services
    • Discovery Proteomics
    • Efficacy Models
  • Press
  • Portal
  • Contact Us
  • General Info
    • Terms
    • Privacy
Yatiri Bio © 2022. All rights reserved.